Back to results
US 2008/0199491 A1Published application
Sustained Release Vaccine Composition
AssigneeVirbac
InventorsMalcolm Brandon, Serge Martinod
Life of this patent
Estimating the term…
Abstract
A non-liquid vaccine composition including one or more antigen component(s); a pharmaceutically acceptable non-liquid adjuvant therefor; and optionally a non-liquid vaccine protection agent.
Claims26
1-84. (canceled)
A non-liquid vaccine composition including:
- one or more antigen component(s);
- a pharmaceutically acceptable non-liquid adjuvant therefor;
- and
- optionally a non-liquid vaccine protection agent.
1 more element
A sustained release vaccine apparatus, the apparatus including:
- a non-liquid vaccine composition including:
- one or more antigen component(s);
- a pharmaceutically acceptable non-liquid adjuvant therefor;
- a sustained release support material;
- and optionally
- a non-liquid vaccine protection agent
- and providing in use, a release rate sufficient to initiate and/or stimulate and/or maintain an immune response.
4 more elements
A sustained release kit including:
- a vaccine delivery apparatus;
- and
- a vaccine composition including:
- one or more antigen component(s);
- a pharmaceutically acceptable non-liquid mineral salt adjuvant therefor;
- a sustained release support material;
- and optionally
- a vaccine protection agent;
- and/or
- a pharmaceutically acceptable carrier.
7 more elements
A method for the therapeutic or prophylactic treatment of an indication in an animal (including a human) requiring such treatment, which method includes administering to the animal a vaccine composition including:
- one or more antigen component(s);
- a pharmaceutically acceptable non-liquid adjuvant therefor;
- and optionally
- a vaccine protection agent;
- and/or
- a pharmaceutically acceptable carrier.
3 more elements
Dependencies are inferred from the claim text.